Literature DB >> 6456097

Suppressor cell function in a family with familial Mediterranean fever.

D N Ilfeld, S Weil, O Kuperman.   

Abstract

Defective suppressor cell function has been demonstrated in several diseases but has not been tested in familial Mediterranean fever (FMF). We tested the ability of concanavalin A-activated suppressor cells from one family with FMF to inhibit the proliferation of phytohaemagglutinin-stimulated responder cells from normal volunteers. Four FMF patients tested between acute attacks had a mean (+/- s.e.) per cent suppression (5 +/- 2) which was significantly (P less than 0.0005) less than an FMF patient tested during a spontaneous remission (47 +/- 3), 10 healthy family members (41 +/- 6) and eight normal volunteers (45 +/- 4). Since FMF is inherited as an autosomal recessive disorder, deficient suppressor cell function is expressed in homozygotes between acute attacks, but not in a homozygote in spontaneous remission, homozygotes who are phenotypically normal, nor heterozygotes. This suggests that the suppressor cell abnormality in this family is probably related to the pathogenesis of FMF rather than representing a genetic marker of FMF or non-specific depression by disease activity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6456097      PMCID: PMC1537291     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  Suppressor T-cell abnormality in idiopathic systemic lupus erythematosus.

Authors:  N I Abdou; A Sagawa; E Pascual; J Hebert; S Sadeghee
Journal:  Clin Immunol Immunopathol       Date:  1976-09

2.  Decreased suppressor cell activity in inflammatory bowel disease.

Authors:  H J Hodgson; J R Wands; K J Isselbacher
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

3.  Immunoregulatory aberrations in systemic lupus erythematosus.

Authors:  A S Fauci; A D Steinberg; B F Haynes; G Whalen
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

4.  Amelioration of familial Mediterranean fever during hemodialysis.

Authors:  D Rubinger; M M Friedlaender; M M Popovtzer
Journal:  N Engl J Med       Date:  1979-07-19       Impact factor: 91.245

Review 5.  Familial Mediterranean fever. A survey of 470 cases and review of the literature.

Authors:  E Sohar; J Gafni; M Pras; H Heller
Journal:  Am J Med       Date:  1967-08       Impact factor: 4.965

6.  Studies on suppressor cell function in thyroid diseases.

Authors:  N Aoki; K M Pinnamaneni; L J DeGroot
Journal:  J Clin Endocrinol Metab       Date:  1979-05       Impact factor: 5.958

7.  Suppressor cell function in psoriasis.

Authors:  D N Suader; P L Bailin; J Sundeen; R S Krakauer
Journal:  Arch Dermatol       Date:  1980-01

8.  Effect of prophylactic colchicine therapy on leukocyte function in patients with familial Mediterranean fever.

Authors:  C A Dinarello; M J Chusid; A S Fauci; J I Gallin; D C Dale; S M Wolff
Journal:  Arthritis Rheum       Date:  1976 May-Jun

9.  Familial abnormalities of suppressor-cell function in systemic lupus erythematosus.

Authors:  K B Miller; R S Schwartz
Journal:  N Engl J Med       Date:  1979-10-11       Impact factor: 91.245

10.  [HLA markers and periodic disease [familial Mediterranean fever (F.M.F.)] (author's transl)].

Authors:  Y Chaouat; J P Tormen; P Godeau; J P Camus; M F Kahn; A Ryckewaert; J E Laula; C J Menkes; M Schmid; J Hors
Journal:  Nouv Presse Med       Date:  1977-10-08
  10 in total
  5 in total

1.  Correction of a suppressor cell deficiency in four patients with familial Mediterranean fever by in vitro or in vivo colchicine.

Authors:  D Ilfeld; O Kuperman
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

2.  Correction of a suppressor cell deficiency in familial Mediterranean fever by colchicine.

Authors:  D Ilfeld; S Weil; O Kuperman
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

3.  Effect of colchicine on immunoregulatory abnormalities in familial Mediterranean fever.

Authors:  M Schlesinger; D Ilfeld; Z T Handzel; Y Altman; O Kuperman; S Levin; C Bibi; L Netzer; N Trainin
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

4.  Serum concentration and urinary excretion of beta 2-microglobulin and microalbuminuria in familial Mediterranean fever.

Authors:  U Saatci; S Ozdemir; S Ozen; A Bakkaloglu
Journal:  Arch Dis Child       Date:  1994-01       Impact factor: 3.791

5.  Co-existence of Hashimoto's thyroiditis with familial Mediterranean fever: is there a pathophysiological association between the two diseases?

Authors:  E Gulcan; A Gulcan; M Koplay; A Alcelik; U Korkmaz
Journal:  Clin Exp Immunol       Date:  2009-02-19       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.